Evidence map›Paper›PMID 27694927›Full record

ArticleLeukemia2017

A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1.

J Vijayakrishnan, R Kumar, M Y R Henrion, A V Moorman, P S Rachakonda, I Hosen, M I da Silva Filho, A Holroyd, S E Dobbins, R Koehler and 19 more

Open access · hybridAbstract read
In one paragraph

Article in Leukemia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 6 pooled it
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 6 syntheses or guidelines pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Characterization of Genetic Etiologic Factors for Pediatric Acute Lymphoblastic Leukemia in Large Childhood Cancer Survivorship Cohorts.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Acute lymphoblastic leukaemia.Nature reviews. Disease primers · 2024
    Review
  19. Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 14 institutions in 4 countries.

J VijayakrishnanDivision of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK.
R KumarDivision of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
M Y R HenrionDivision of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK.
A V MoormanLeukemia Research Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
P S RachakondaDivision of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
I HosenDivision of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
M I da Silva FilhoDivision of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
A HolroydDivision of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK.
S E DobbinsDivision of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK.
R KoehlerDepartment of Human Genetics, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
H ThomsenDivision of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
J A IrvingLeukemia Research Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
J M AllanLeukemia Research Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
T LightfootDepartment of Health Sciences, Epidemiology and Cancer Statistics Group, University of York, York, UK.
E RomanDepartment of Health Sciences, Epidemiology and Cancer Statistics Group, University of York, York, UK.
S E KinseyDepartment of Paediatric and Adolescent Haematology and Oncology, Leeds General Infirmary, Leeds, UK.
E SheridanMedical Genetics Research Group, Leeds Institute of Biomedical & Clinical Sciences, University of Leeds, Leeds, UK.
P D ThompsonPaediatric and Familial Cancer Research Group, Institute of Cancer Sciences, University of Manchester, St Mary's Hospital, Manchester, UK.
P HoffmannInstitute of Human Genetics, University of Bonn, Bonn, Germany.
M M NöthenInstitute of Human Genetics, University of Bonn, Bonn, Germany.
S Heilmann-HeimbachInstitute of Human Genetics, University of Bonn, Bonn, Germany.
K H JöckelInstitute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany.
M GreavesHaemato-Oncology Research Unit, Division of Molecular Pathology, Institute of Cancer Research, Sutton, UK.
C J HarrisonLeukemia Research Group, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
C R BartramDepartment of Human Genetics, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
M SchrappeGeneral Paediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.
M StanullaDepartment of Paediatric Haematology and Oncology, Hannover Medical School, Hannover, Germany.
K HemminkiDivision of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
R S HoulstonDivision of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK.
Institute of Cancer Research · GBGerman Cancer Research Center · DENewcastle University · GBHeidelberg University · DEUniversity of Bonn · DEUniversity of York · GBDepartment of Biomedicine Basel · CHInstitut für Medizinische Informatik, Biometrie und Epidemiologie · DELeeds General Infirmary · GBLund University · SEMedizinische Hochschule Hannover · DESt Mary's Hospital · GBUniversity Hospital Schleswig-Holstein · DEUniversity of Leeds · GB

Funding

Medical Research Council G9815508Medical Research Council MC_PC_15018Wellcome Trust
6 · The paper itself

Abstract

Genome-wide association studies (GWASs) have shown that common genetic variation contributes to the heritable risk of childhood acute lymphoblastic leukemia (ALL). To identify new susceptibility loci for the largest subtype of ALL, B-cell precursor ALL (BCP-ALL), we conducted a meta-analysis of two GWASs with imputation using 1000 Genomes and UK10K Project data as reference (totaling 1658 cases and 7224 controls). After genotyping an additional 2525 cases and 3575 controls, we identify new susceptibility loci for BCP-ALL mapping to 10q26.13 (rs35837782, LHPP, P=1.38 × 10

Indexed as

Chromosomes, Human, Pair 10Chromosomes, Human, Pair 12Genetic LociGenetic Predisposition to DiseaseCase-Control StudiesChildChild, PreschoolChromatin Assembly and DisassemblyChromosome DeletionComputational BiologyFemaleGene Expression ProfilingGenome-Wide Association StudyGenotypeHigh-Throughput Nucleotide SequencingHumans

Identifiers

PMID27694927
PMCPMC5336191
OpenAlexW2529191021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.